Tempest Therapeutics, Inc.
USD1.10
+0.01 (+0.45%)
CEO
Matthew Angel
IPO Date
2012-11-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.07
Prev. Close
$1.10
Day Low
$1.07
Day High
$1.12
52W Low
$1.02
52W High
$12.23
Market Cap
$0.00B
Volume
0.01M
| 25,000 |
| $1.27 |
| 17 Jun 2026 | Yee John D. | — | Disposed | 0 | $0.00 |
| 8 Jun 2026 | Richey William Drake | director | Disposed | 0 | $0.00 |
| 8 Jun 2026 | Richey William Drake | director | A-Award | Acquired | 25,000 | $1.27 |
| 2 Apr 2026 | Trojanowski Justin | Corporate Controller | A-Award | Acquired | 22,000 | $1.64 |
| 2 Apr 2026 | Maestas Nicholas | Chief Financial Officer | A-Award | Acquired | 140,000 | $1.64 |
| 25 Mar 2026 | Angel Matthew | director, 10 percent owner, officer: CEO and President | P-Purchase | Acquired | 231,482 | $2.16 |
| 6 Feb 2026 | Angel Matthew | director, 10 percent owner, officer: CEO and President | A-Award | Acquired | 269,621 | $2.38 |
| 6 Feb 2026 | Angel Matthew | director, 10 percent owner, officer: CEO and President | Disposed | 0 | $0.00 |